Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 27,241 | 17,129 | 34,463 | 26,556 | 8,319 |
| Operating Income | -27,241 | -17,129 | -34,463 | -26,556 | -8,319 |
| Interest Expense | 653 | 498 | 223 | 499 | 320 |
| Other Income | 2,998 | 5,809 | 17,107 | 540 | 2,220 |
| Pre-tax Income | -24,896 | -11,818 | -17,579 | -26,515 | -6,419 |
| Income Tax | -381 | 83 | -1,521 | 133 | 198 |
| Net Income Continuous | -24,515 | -11,901 | -16,058 | -26,648 | -6,617 |
| Minority Interests | N/A | N/A | N/A | N/A | -15 |
| Net Income | $-24,515 | $-11,901 | $-16,058 | $-26,648 | $-6,602 |
| EPS Basic Total Ops | -15.65 | -6,031.31 | -1,857,910.00 | -4.19 | -2.03 |
| EPS Basic Continuous Ops | -15.26 | -3,515.81 | -1,417,259.00 | -4.19 | -2.03 |
| EPS Diluted Total Ops | -15.65 | -6,031.31 | -1,857,910.00 | -4.19 | -2.03 |
| EPS Diluted Continuous Ops | -15.26 | -3,515.81 | -1,417,259.00 | -4.19 | -2.03 |
| EPS Diluted Before Non-Recurring Items | -15.65 | -6,162.16 | N/A | N/A | N/A |
| EBITDA(a) | $-17,529 | $-17,092 | $-16,832 | $-26,450 | $-8,273 |